Staff Scientist, Analytical Development, Nucleic Acid Therapeutics, Thermo Fisher Scientific
BIOGRAPHY
Speaker
Abstract
Oligonucleotide therapeutics have emerged as a promising novel class of drugs to treat a wide range of diseases. The development of these therapeutics relies on the proper use of chemical building blocks called phosphoramidites to generate high‑quality oligonucleotides. This webinar discusses techniques for phosphoramidite synthesis, selection, and evaluation for the development of oligonucleotide drugs.
Learning Objectives:
1. Identify phosphoramidites for oligonucleotide therapeutic development and manufacturing.
2. Review phosphoramidite impurities and their potential impacts on oligonucleotide therapeutics.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...